Boditech Med Inc. (KOSDAQ:206640)

South Korea flag South Korea · Delayed Price · Currency is KRW
11,890
-110 (-0.92%)
Apr 28, 2026, 3:30 PM KST
-32.25%
Market Cap 241.90B
Revenue (ttm) 162.09B
Net Income (ttm) 23.65B
Shares Out 20.34M
EPS (ttm) 1,091.00
PE Ratio 10.90
Forward PE n/a
Dividend 150.00 (1.25%)
Ex-Dividend Date Mar 31, 2026
Volume 40,406
Average Volume 49,885
Open 12,000
Previous Close 12,000
Day's Range 11,860 - 12,080
52-Week Range 10,370 - 18,670
Beta 0.45
RSI 51.49
Earnings Date May 12, 2026

About Boditech Med

Boditech Med Inc. offers instruments and diagnostic reagents in South Korea and internationally. The company offers instruments, including ichroma II, diagnostic immuno-analyzer to measure the presence of various biomarkers for cardiac, cancer, hormones, infectious diseases, autoimmune diseases, and metabolic diseases; ichroma III, a high-throughput immuno-analyzer that enables simultaneous testing for various parameters; ExAmplar, a compact real time PCR that detects virus/bacteria quantitatively or qualitatively using ready-to-use cartridges;... [Read more]

Sector Healthcare
Founded 1998
Employees 541
Stock Exchange KOSDAQ
Ticker Symbol 206640
Full Company Profile

Financial Performance

In 2025, Boditech Med's revenue was 162.09 billion, an increase of 17.32% compared to the previous year's 138.16 billion. Earnings were 23.65 billion, a decrease of -13.23%.

Financial Statements

News

There is no news available yet.